T10	Treatment 140 158	TNF-alpha blockers
T12	Effect 169 201	cutaneous inflammatory reactions
T13	Severity_cue 6 22	mild to moderate
T15	Drug 140 158	TNF-alpha blockers
T17	Speculation_cue 127 136	potential
T18	Effect 23 56	application site reactions (ASRs)
T19	Treatment 112 121	imiquimod
T20	Drug 112 121	imiquimod
T11	Adverse_event 162 168	elicit
T16	Adverse_event 96 106	associated
E1	Adverse_event:T11 arg:T10 arg2:T12
E2	Adverse_event:T16 arg:T18 arg2:T19
R1	has_cue Arg1:E1 Arg2:T17	
R2	has_cue Arg1:E2 Arg2:T13	
A1	Speculated E1
A2	Severity E2 Medium